Where Will NuScale Power Stock Be in 5 Years?

NuScale Power faces meaningful execution and financing risk: its first operating plant may not come online until 2030 at the earliest, while its TVA project is not slated to begin construction until late 2028 and finish in 2032. The company reported a record 2025 net loss of $664 million and has diluted shareholders heavily, with share count up roughly 1,500% since its IPO and more than doubling over the past 12 months. The article is cautious on the stock’s five-year outlook despite long-term upside in small modular reactors.

Analysis

SMR is now a classic “authorization optionality vs execution reality” trade: the regulatory moat is real, but the cash conversion is not. The market is likely overpaying for the first-mover label while underestimating how long customer commitments stay soft when a project is still years from first concrete pour; that gap tends to widen, not shrink, as financing costs stay elevated and each delay forces larger equity raises. The bigger second-order effect is that every incremental delay improves the competitive setup for later entrants with stronger balance sheets, because utility buyers tend to value delivery certainty over design pedigree once the project moves from policy conversation to procurement.

The TVA pipeline matters less as a revenue event and more as a credibility event. If that project slips again, the stock’s narrative can de-rate quickly because the bull case depends on a sequence of milestones compounding, not one binary win; in that setup, a single miss can compress multiple years of expected upside. Conversely, a firm construction start would likely re-rate the entire SMR peer basket and pull in adjacent beneficiaries across engineering, grid equipment, and nuclear supply chain names that have been waiting for proof of bankability.

The dilution profile is the hidden killer: repeated equity issuance turns long-dated upside into a treadmill where per-share value can lag headline project value. That means even “good news” may not translate into durable equity returns unless management can secure project-level financing or strategic capital with far less shareholder damage. The contrarian view is that the stock may still be too cheap for a true option on U.S. nuclear deployment, but too expensive for a company that has not yet proven it can fund and build at scale without recurring equity resets.

Key Decisions for Investors

• Avoid chasing SMR into strength; treat it as a long-dated call option only for accounts that can tolerate 24-36 months of dilution and milestone risk. Prefer waiting for a project-financing announcement or actual ground-breaking before adding risk.
• For a relative-value expression, short SMR against a basket of more self-funded nuclear/utility-adjacent beneficiaries once SMR rallies on headlines; the pair benefits if regulatory optionality outpaces execution and dilution continues.
• Monitor TVA-related milestones over the next 6-12 months; if schedule confidence improves, use call spreads in SMR rather than stock to cap dilution risk and keep theta manageable.
• Long-term, favor the picks-and-shovels beneficiaries of any nuclear buildout over SMR itself: engineering, grid, and heavy equipment suppliers are better risk-adjusted expressions because they get paid earlier in the project cycle.
• If SMR sells off on another delay but retains regulatory credibility, consider a tactical bounce trade only via limited-risk options; the stock can overshoot both directions on narrative shifts, but the fundamental path remains capital-intensive.